Andrei Mariandyshev

1.8k total citations
16 papers, 212 citations indexed

About

Andrei Mariandyshev is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Andrei Mariandyshev has authored 16 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Andrei Mariandyshev's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (5 papers). Andrei Mariandyshev is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (5 papers). Andrei Mariandyshev collaborates with scholars based in Russia, United Kingdom and Norway. Andrei Mariandyshev's co-authors include Gunnar Bjune, Per Sandven, Dominique A. Caugant, O. S. Toungoussova, Baranov Aa, Turid Mannsåker, Ulf R. Dahle, S. Bertel Squire, Elena Gospodarevskaya and Russell Dacombe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Bulletin of the World Health Organization.

In The Last Decade

Andrei Mariandyshev

15 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrei Mariandyshev Russia 9 168 141 68 30 10 16 212
Boris Y. Kazennyy United States 4 162 1.0× 136 1.0× 55 0.8× 22 0.7× 7 0.7× 4 199
Ma Tarcela Gler United States 3 196 1.2× 161 1.1× 72 1.1× 21 0.7× 8 0.8× 3 233
James C. M. Brust United States 6 165 1.0× 111 0.8× 66 1.0× 21 0.7× 6 0.6× 7 206
Natavan Alikhanova United States 5 160 1.0× 125 0.9× 44 0.6× 37 1.2× 10 1.0× 7 169
Hyungseok Kang South Korea 8 255 1.5× 187 1.3× 105 1.5× 41 1.4× 10 1.0× 14 304
Debrah Vambe South Africa 7 149 0.9× 104 0.7× 49 0.7× 28 0.9× 4 0.4× 17 188
Elisa H. Ignatius United States 9 272 1.6× 211 1.5× 78 1.1× 45 1.5× 12 1.2× 14 327
Saverio De Lorenzo Italy 5 184 1.1× 137 1.0× 78 1.1× 27 0.9× 29 2.9× 6 201
Sarin Chan France 10 213 1.3× 202 1.4× 141 2.1× 31 1.0× 7 0.7× 11 295
Fathima Rahman India 10 224 1.3× 187 1.3× 116 1.7× 25 0.8× 20 2.0× 19 290

Countries citing papers authored by Andrei Mariandyshev

Since Specialization
Citations

This map shows the geographic impact of Andrei Mariandyshev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Mariandyshev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Mariandyshev more than expected).

Fields of papers citing papers by Andrei Mariandyshev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei Mariandyshev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Mariandyshev. The network helps show where Andrei Mariandyshev may publish in the future.

Co-authorship network of co-authors of Andrei Mariandyshev

This figure shows the co-authorship network connecting the top 25 collaborators of Andrei Mariandyshev. A scholar is included among the top collaborators of Andrei Mariandyshev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrei Mariandyshev. Andrei Mariandyshev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jackson, Charlotte, Edith B. Milanzi, Siobhan Crichton, et al.. (2024). Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study. PLoS ONE. 19(8). e0293272–e0293272.
2.
Howell, Pauline, et al.. (2022). Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities. Pathogens. 11(4). 381–381. 10 indexed citations
3.
Turkova, Anna, et al.. (2022). Fluoroquinolone preventive therapy for children exposed to MDR-TB. The International Journal of Tuberculosis and Lung Disease. 26(2). 171–173. 5 indexed citations
4.
Mariandyshev, Andrei, et al.. (2020). The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169). SHILAP Revista de lepidopterología. 92(3). 61–72. 16 indexed citations
5.
Хохлов, А. Л., et al.. (2020). Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе. SHILAP Revista de lepidopterología. 92(12). 165–171. 4 indexed citations
6.
Hinderaker, Sven Gudmund, et al.. (2019). Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia. Infection Genetics and Evolution. 73. 358–361. 2 indexed citations
7.
Bogdanova, Elena, Andrei Mariandyshev, Donald A. Enarson, et al.. (2019). Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation. PLoS ONE. 14(1). e0211203–e0211203. 8 indexed citations
8.
Chimzizi, Rhehab, Judith Mzyece, Elizabeth Chizema, et al.. (2017). What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?. The International Journal of Tuberculosis and Lung Disease. 21(8). 887–893. 3 indexed citations
9.
Bogdanova, Elena, Donald A. Enarson, Anne Detjen, et al.. (2016). The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia. PLoS ONE. 11(4). e0152761–e0152761. 34 indexed citations
10.
Creswell, Jacob, Suvanand Sahu, Kuldeep Singh Sachdeva, et al.. (2014). Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda. Bulletin of the World Health Organization. 92(6). 459–460. 19 indexed citations
11.
Aa, Baranov, et al.. (2009). Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia.. PubMed. 13(10). 1288–93. 22 indexed citations
12.
Toungoussova, O. S., Andrei Mariandyshev, Gunnar Bjune, Dominique A. Caugant, & Per Sandven. (2005). Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. European Journal of Clinical Microbiology & Infectious Diseases. 24(3). 202–206. 32 indexed citations
13.
Toungoussova, O. S., et al.. (2004). Impact of Drug-Resistant Mycobacterium tuberculosis on Treatment Outcome of Culture-Positive Cases of Tuberculosis in the Archangel Oblast, Russia, in 1999. European Journal of Clinical Microbiology & Infectious Diseases. 23(3). 174–179. 17 indexed citations
14.
Caugant, Dominique A., et al.. (2002). Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.. PubMed. 6(5). 406–14. 37 indexed citations
15.
Mariandyshev, Andrei, et al.. (2001). [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].. PubMed. 48–9. 1 indexed citations
16.
Mariandyshev, Andrei, et al.. (1997). [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].. PubMed. 19–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026